New RA drug enters human safety testing
Disease control
Recruiting now
This early-stage study tests a new medicine called SR-878 in 27 adults with rheumatoid arthritis. The goal is to find a safe dose by checking for side effects. Participants will take the drug once and be monitored for about 16 weeks. This is not a cure; it aims to control the dis…
Phase: PHASE1 • Sponsor: SciRhom GmbH • Aim: Disease control
Last updated May 11, 2026 20:41 UTC